Denosumab for The Treatment of Bone Disease in Solid Tumors and Multiple Myeloma

10.1158/1078-0432.CCR-10-0600

10.1038/nature01658

10.1038/nrd3705

10.1006/jsre.2001.6204

10.1073/pnas.201394498

10.1038/nrc.2016.44

10.1158/0008-5472.CAN-06-1210

10.1182/blood-2005-07-2719

10.1172/JCI200523394

10.1073/pnas.110553397

10.1038/nrc867

10.1056/NEJMct1004903

10.6004/jnccn.2009.0076

10.1002/cncr.11701

10.1200/JCO.2003.04.105

10.1093/jnci/94.19.1458

Wong MH , StocklerMR, PavlakisN. Bisphosphonates and other bone agents for breast cancer. Cochrane Database Syst. Rev. (2), CD003474 (2012).

10.4065/78.1.21

10.1200/JCO.2017.72.2975

10.1016/S0140-6736(10)62051-X

10.1016/S1470-2045(11)70157-7

10.1182/blood-2011-11-392522

10.6004/jnccn.2017.0023

10.1200/JCO.2012.47.7901

10.1016/j.bone.2010.11.020

10.1056/NEJMoa0809493

10.1200/JCO.2005.06.091

10.1093/jnci/dji002

10.1158/1078-0432.CCR-07-5234

10.1200/JCO.2007.11.8604

10.1158/1078-0432.CCR-05-1933

10.1200/JCO.2008.19.2146

10.1200/JCO.2010.29.7101

10.1158/1078-0432.CCR-11-3310

10.1016/S0140-6736(10)62344-6

10.1200/JCO.2010.31.3304

10.1093/annonc/mds175

10.1038/ki.2008.356

Rosen LS , GordonD, KaminskiMet al. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a Phase III, double-blind, comparative trial. Cancer J.7(5), 377–387 (2001).

10.1200/JCO.2007.12.1269

10.1016/j.ejca.2012.08.002

10.1158/1078-0432.CCR-07-1430

10.7326/0003-4819-144-10-200605160-00009

10.1093/annonc/mdr435

10.1007/s00520-015-2904-5

10.1002/pds.4045

10.1159/000380960

10.1177/1078155216628325

10.1038/bcj.2015.96

Raje N , TerposE, WillenbacherWet al. An international randomized, double blind trial comparing denosumab with zoledronic acid for the treatment of bone disease in patients with newly diagnosed multiple myeloma. Presented at: International Myeloma Workshop. Santiago, Chile, 11–12 August 2017 (Abstract OPO-046).

10.1016/j.ejca.2017.02.021

10.1016/j.humpath.2005.07.005

10.1016/S1470-2045(10)70010-3

10.1016/S1470-2045(13)70277-8

10.1016/S0140-6736(11)61226-9

10.1200/JCO.2012.44.6716

10.1016/j.eururo.2014.02.014

10.1016/S0140-6736(15)60908-4

10.1200/JCO.2016.70.7257